S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Climate bill: Could coal communities shift to nuclear?
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
The Day of Financial Reckoning Is Near (Ad)
Former Deutsche Bank Co-CEO Anshu Jain dies
Ship carrying grain for hungry Ethiopia leaves Ukraine
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Apple’s Next “Star Product” Could Replace The iPhone? (Ad)pixel
NYSE:COO

Cooper Companies - COO Stock Forecast, Price & News

$334.07
+5.33 (+1.62%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$328.54
$334.18
50-Day Range
$288.50
$347.51
52-Week Range
$284.01
$463.59
Volume
147,404 shs
Average Volume
240,743 shs
Market Capitalization
$16.48 billion
P/E Ratio
17.55
Dividend Yield
0.02%
Price Target
$425.67

Cooper Companies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
27.4% Upside
$425.67 Price Target
Short Interest
Healthy
2.34% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.39
Upright™ Environmental Score
News Sentiment
0.10mentions of Cooper Companies in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.15%
From $13.17 to $14.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.08 out of 5 stars

Medical Sector

25th out of 1,135 stocks

Ophthalmic Goods Industry

1st out of 7 stocks

COO stock logo

About Cooper Companies (NYSE:COO) Stock

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on COO shares. Stephens cut their target price on shares of Cooper Companies from $500.00 to $460.00 and set an "overweight" rating for the company in a research note on Friday, June 3rd. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $475.00 to $450.00 in a research note on Monday, June 6th. TheStreet cut shares of Cooper Companies from a "b-" rating to a "c+" rating in a research note on Monday, July 18th. Wells Fargo & Company dropped their price objective on shares of Cooper Companies from $380.00 to $370.00 and set an "overweight" rating for the company in a research note on Wednesday. Finally, Robert W. Baird dropped their price objective on shares of Cooper Companies from $437.00 to $392.00 in a research note on Thursday, May 26th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $425.67.

Cooper Companies Price Performance

COO Stock opened at $334.07 on Friday. The company has a quick ratio of 0.69, a current ratio of 1.05 and a debt-to-equity ratio of 0.33. Cooper Companies has a 12 month low of $284.01 and a 12 month high of $463.59. The firm has a market cap of $16.48 billion, a P/E ratio of 17.55, a P/E/G ratio of 2.54 and a beta of 0.90. The company's 50-day moving average price is $317.34 and its two-hundred day moving average price is $361.33.

Cooper Companies (NYSE:COO - Get Rating) last released its earnings results on Thursday, June 2nd. The medical device company reported $3.24 EPS for the quarter, missing the consensus estimate of $3.41 by ($0.17). Cooper Companies had a net margin of 30.20% and a return on equity of 9.48%. The firm had revenue of $829.80 million during the quarter, compared to the consensus estimate of $821.03 million. During the same period in the prior year, the business earned $3.38 earnings per share. Cooper Companies's quarterly revenue was up 15.3% compared to the same quarter last year. On average, analysts anticipate that Cooper Companies will post 13.17 earnings per share for the current fiscal year.

Cooper Companies Announces Dividend

The company also recently announced a semi-annual dividend, which was paid on Thursday, August 11th. Shareholders of record on Wednesday, July 27th were issued a $0.03 dividend. The ex-dividend date of this dividend was Tuesday, July 26th. Cooper Companies's dividend payout ratio is currently 0.32%.

Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

COO Stock News Headlines

Why companies are rescinding job offers
Recap: Mr. Cooper Gr Q2 Earnings
See More Headlines
Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

COO Company Calendar

Last Earnings
6/02/2022
Ex-Dividend for 8/11 Dividend
7/26/2022
Dividend Payable
8/11/2022
Today
8/14/2022
Next Earnings (Confirmed)
8/31/2022
Fiscal Year End
10/31/2022

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
CUSIP
21664840
Employees
12,000
Year Founded
1958

Price Target and Rating

Average Stock Price Forecast
$425.67
High Stock Price Forecast
$495.00
Low Stock Price Forecast
$370.00
Forecasted Upside/Downside
+27.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$2.94 billion
Pretax Margin
15.96%

Debt

Sales & Book Value

Annual Sales
$2.92 billion
Cash Flow
$19.66 per share
Book Value
$140.80 per share

Miscellaneous

Free Float
48,497,000
Market Cap
$16.48 billion
Optionable
Optionable
Beta
0.90

Social Links















COO Stock - Frequently Asked Questions

Should I buy or sell Cooper Companies stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" COO shares.
View COO analyst ratings
or view top-rated stocks.

What is Cooper Companies' stock price forecast for 2022?

10 brokers have issued twelve-month price targets for Cooper Companies' shares. Their COO share price forecasts range from $370.00 to $495.00. On average, they predict the company's share price to reach $425.67 in the next year. This suggests a possible upside of 27.4% from the stock's current price.
View analysts price targets for COO
or view top-rated stocks among Wall Street analysts.

How have COO shares performed in 2022?

Cooper Companies' stock was trading at $418.94 on January 1st, 2022. Since then, COO shares have decreased by 20.3% and is now trading at $334.07.
View the best growth stocks for 2022 here
.

Are investors shorting Cooper Companies?

Cooper Companies saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 1,260,000 shares, a drop of 20.8% from the June 15th total of 1,590,000 shares. Based on an average daily trading volume, of 348,400 shares, the days-to-cover ratio is currently 3.6 days. Approximately 2.6% of the company's stock are short sold.
View Cooper Companies' Short Interest
.

When is Cooper Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 31st 2022.
View our COO earnings forecast
.

How can I listen to Cooper Companies' earnings call?

Cooper Companies will be holding an earnings conference call on Wednesday, August 31st at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NYSE:COO) issued its earnings results on Thursday, June, 2nd. The medical device company reported $3.24 earnings per share for the quarter, missing analysts' consensus estimates of $3.41 by $0.17. The medical device company had revenue of $829.80 million for the quarter, compared to analyst estimates of $821.03 million. Cooper Companies had a trailing twelve-month return on equity of 9.48% and a net margin of 30.20%. The firm's revenue was up 15.3% on a year-over-year basis. During the same period in the previous year, the firm earned $3.38 earnings per share.
Read the conference call transcript
.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies announced a semi-annual dividend on Thursday, July 14th. Stockholders of record on Wednesday, July 27th will be paid a dividend of $0.03 per share on Thursday, August 11th. The ex-dividend date of this dividend is Tuesday, July 26th.
Read our dividend analysis for COO
.

Is Cooper Companies a good dividend stock?

Cooper Companies (NYSE:COO) pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.02%. The dividend payout ratio is 0.32%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COO will have a dividend payout ratio of 0.41% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for COO.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies issued an update on its FY 2022 earnings guidance on Thursday, June, 30th. The company provided EPS guidance of $13.09-$13.29 for the period, compared to the consensus EPS estimate of $13.74. The company issued revenue guidance of $3.28 billion-$3.31 billion, compared to the consensus revenue estimate of $3.29 billion.

What is Robert S. Weiss' approval rating as Cooper Companies' CEO?

8 employees have rated Cooper Companies Chief Executive Officer Robert S. Weiss on Glassdoor.com. Robert S. Weiss has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by many different institutional and retail investors. Top institutional investors include Veritas Asset Management LLP (4.17%), Kayne Anderson Rudnick Investment Management LLC (2.57%), JPMorgan Chase & Co. (2.18%), Victory Capital Management Inc. (2.04%), Massachusetts Financial Services Co. MA (1.93%) and Allianz Asset Management GmbH (1.80%). Insiders that own company stock include Agostino Ricupati, Albert G White III, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Holly R Sheffield, Jody S Lindell, Michael Kalkstein, Robert D Auerbach and Robert S Weiss.
View institutional ownership trends
.

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $334.07.

How much money does Cooper Companies make?

Cooper Companies (NYSE:COO) has a market capitalization of $16.48 billion and generates $2.92 billion in revenue each year. The medical device company earns $2.94 billion in net income (profit) each year or $19.04 on an earnings per share basis.

How many employees does Cooper Companies have?

The company employs 12,000 workers across the globe.

Does Cooper Companies have any subsidiaries?

The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.
Read More

When was Cooper Companies founded?

Cooper Companies was founded in 1958.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The official website for the company is www.coopercos.com. The medical device company can be reached via phone at (925) 460-3600, via email at ir@cooperco.com, or via fax at 925-460-3649.

This page (NYSE:COO) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.